HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

nuclear matrix protein 22

a commercially available tumor marker for the detection of cell carcinoma of the urinary tract
Also Known As:
NMP22
Networked: 195 relevant articles (25 outcomes, 42 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Shariat, Shahrokh F: 16 articles (11/2014 - 12/2003)
2. Lotan, Yair: 13 articles (11/2014 - 05/2005)
3. Casella, Roberto: 9 articles (03/2008 - 12/2003)
4. Svatek, Robert S: 7 articles (11/2014 - 04/2006)
5. Stenzl, Arnulf: 7 articles (01/2014 - 01/2009)
6. Karakiewicz, Pierre I: 7 articles (03/2012 - 05/2005)
7. Sagalowsky, Arthur I: 7 articles (07/2009 - 03/2004)
8. Schwentner, Christian: 6 articles (01/2014 - 01/2012)
9. Grossman, H Barton: 6 articles (10/2011 - 02/2005)
10. Boman, Hans: 5 articles (03/2008 - 01/2002)

Related Diseases

1. Urinary Bladder Neoplasms (Bladder Cancer)
2. Neoplasms (Cancer)
3. Transitional Cell Carcinoma
4. Hematuria
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. nuclear matrix protein 22
2. Antigens
3. Telomerase (Telomerase Reverse Transcriptase)
4. Biological Tumor Markers (Tumor Markers)
5. Hemoglobins (Hemoglobin)
6. formycin diphosphate (FDP)
7. Fibronectins (Fibronectin)
8. antigen CYFRA21.1
9. Biological Markers (Surrogate Marker)
10. Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)

Related Therapies and Procedures

1. Urinary Diversion (Ileal Conduit)
2. Aftercare (After-Treatment)
3. Cystectomy
4. Stents
5. Anesthesia